)
Visual
earnings real time
Revvity
Revvity (RVTY) investor relations material
Revvity Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary2 Feb, 2026
Executive summary
Q4 2025 revenue reached $772 million, up 6% year-over-year with 4% organic growth, and adjusted EPS was $1.70, up 20% year-over-year, closing the year above initial guidance despite market and policy headwinds.
Full-year 2025 revenue totaled $2.86 billion, up 4% year-over-year, with adjusted EPS at $5.06, up from $4.90 in 2024, and 3% organic growth, demonstrating resilience and execution.
Diagnostics and Reproductive Health segments outperformed, with Diagnostics leading Q4 at 7% organic growth and Immunodiagnostics and Reproductive Health both posting strong results.
Over $800 million in share repurchases in 2025, reducing share count by 8.5 million; total repurchases since mid-2023 exceed $1.5 billion.
Launched Signals Xynthetica, an AI Models-as-a-Service platform, and announced collaboration with Lilly's TuneLab.
Financial highlights
Q4 2025 revenue: $772 million, 4% organic growth, 6% total growth; full year: $2.86 billion, 3% organic growth, 4% total growth.
Adjusted operating margin Q4: 29.7% (down 60 bps YoY); full year: 27.1% (down 120 bps YoY).
Adjusted EPS Q4: $1.70, up 20% YoY; full year: $5.06, up 3% YoY.
Free cash flow Q4: $162 million (84% conversion); full year: $515 million (87% conversion).
Net debt to adjusted EBITDA: 2.7x; all debt fixed rate, 2.6% average interest, 6-year maturity.
Outlook and guidance
2026 revenue guidance: $2.96–$2.99 billion, 2–3% organic growth, 1% FX tailwind, and 0.75% M&A contribution.
Adjusted operating margin guidance: 28% for 2026, up from 27.1% in 2025.
Adjusted EPS guidance for 2026: $5.35–$5.45, high single-digit growth.
Adjusted tax rate for 2026: 18%, up from 14.5% in 2025; net interest expense expected at $95 million.
Diluted average share count expected at 112 million for 2026.
Drivers of 2025 adjusted operating margin decline
Why is 2026 organic growth guidance lower?
What is the nature of recurring non-GAAP items?
Xynthetica monetization strategy
What drives China IDX's revised H2 2026 outlook?
Impact of share repurchases on future EPS growth
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- BOROUGE
FY2025 net profit hit $1.1B with 37% EBITDA margin, record sales, and major restructuring. - DCRU
Strong FY2025 growth, high occupancy, and strategic expansion driven by digital demand. - WOSG
Q3 sales growth exceeded expectations, guidance raised, and US presence expanded. - NOBA
Record profit growth, robust capital, and SME expansion drive strong 2025 results. - SF
Margins expanded to 27% despite revenue decline and large non-cash impairments. - IFX
Q1 FY26 revenue up 7% YoY to €3.66bn, led by AI and automotive, with key acquisition and investments. - WRT1V
All-time high profit and cash flow, with robust Marine and Energy growth and major investments. - CB
Record net income and strong underwriting drive robust growth, with positive 2026 outlook. - BERG
EBITA and margins rose 12% with 4% organic growth, supported by acquisitions and efficiency. - APOTEA
Full-year revenue up 10.1%, but Q4 margin dropped to 1.3% on higher costs.
Next Revvity earnings date
Q1 202627 Apr, 2026
Revvity
Next Revvity earnings date
Q1 202627 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Revvity Inc., formerly known as PerkinElmer Inc., is an American life sciences and diagnostics company. It offers a wide range of health science solutions, technologies, expertise, and services, aiming to cover the complete workflow from discovery to development, and diagnosis to cure. The company primarily serves the pharmaceutical and biotechnology industries, with a special focus on cell therapy and gene therapy developments. Revvity operates in two main segments: diagnostics, and life sciences research and laboratory services markets. By providing products, services, and solutions globally, Revvity supports the diagnostics, life sciences, and applied services markets. The company is committed to driving innovation in healthcare, emphasizing the development of technologies and solutions across disease pathways. Revvity Inc. is headquartered in Waltham, Massachusetts, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage